All the negative buzz about pharma buzzwords inspired the creation of the Pharma Marketing Buzzword Bingo Card (shown here) and the Pharma Marketing News 'Pharma Buzzword Survey,' which asked respondents to grade a list of buzzwords commonly heard at conferences and marketing meetings within pharmaceutical companies. This article summarizes the results of that survey.
This article focuses on the risks and benefits of using celebrities and social media to promote pharma brands and proposes that it may be time for the pharma industry to disclose the details of payments made to celebrities as they now are required to do for physician payments.
Welcome to Vol. 14, Issue No. 3 (APRIL 2015) of Pharma Marketing News. Patient centricity, direct-to-consumer advertising, and key opinion leaders are the focus of this issue. All are related in the sense that each area has seen major changes & shifts in thinking with more to come.
This article summarizes the roles of Chief Patient Officers in bringing the patient perspective into their company's work. Sanofi is used as a case study.
In this article, Maureen Winigrad and John Griffith, principals at Centric Infographics, present the latest access data for two infographics campaigns spoonsored by the Epilepsy Foundation and Lunbeck Pharmaceuticals.
This article presents a case study of how patient input has the power to change the course of drug approval. The case is Sprout's ground-breaking patient campaign that played a major role in getting Addyi, a female sexual dysfunction drug, approved by the FDA.
This article summarizes the results of the KOL Name Change Survey and discusses how to change the underlying process by which pharma companies choose KOLs.
The FDA approved a total of 41 new molecular entities (NMEs) and biologics (BLAs) in 201 4but sent out only a meager 10 advertising enforcement letters in 2014, the fewest ever.
This article discusses the pros and cons of safeguards proposed a group of academic physicians (the #MICEproject) to limit pharmaceutical 'detailing' and to 'bring the medical community closer to establishing guidelines for third party activities in Twitter back-channels.'
Welcome to Vol. 14, Issue No. 7 (DECEMBER 2015) of Pharma Marketing News. DTC Ban Revisited, Digital Disruption, Best of 2015, are the themes of this issue.